These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 30305089)

  • 1. Tailoring cells for clinical needs: Meeting report from the Advanced Therapy in Healthcare symposium (October 28-29 2017, Doha, Qatar).
    Deola S; Guerrouahen BS; Sidahmed H; Al-Mohannadi A; Elnaggar M; Elsadig R; Abdelalim EM; Petrovski G; Gadina M; Thrasher A; Wels WS; Hunger SP; Wang E; Marincola FM; ; Maccalli C; Cugno C
    J Transl Med; 2018 Oct; 16(1):276. PubMed ID: 30305089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Personalized Regenerative Medicine.
    Arjmand B; Goodarzi P; Mohamadi-Jahani F; Falahzadeh K; Larijani B
    Acta Med Iran; 2017 Mar; 55(3):144-149. PubMed ID: 28282715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applying value-based strategies to accelerate access to novel cancer medications: guidance from the Oncology Health Economics Expert Panel in Qatar (Q-OHEP).
    Hamad A; Elazzazy S; Bujassoum S; Rasul K; Gaziev J; Cherif H; Al-Boloshi Z; Hanssens Y; Saleh A; Rasheed HA; Al-Badriyeh D; Babiker A; Hmaidan AA; Al-Hail M
    BMC Health Serv Res; 2023 Jan; 23(1):15. PubMed ID: 36609388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The FDA Oncology Center of Excellence and precision medicine.
    Goldberg KB; Blumenthal GM; McKee AE; Pazdur R
    Exp Biol Med (Maywood); 2018 Feb; 243(3):308-312. PubMed ID: 29105511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. International Society for Cell and Gene Therapy of Cancer 2009 Annual Meeting held in Cork, Ireland.
    Guinn B; Casey G; Möller MG; Kasahara N; O'Sullivan GC; Peng KW; Tangney M
    Hum Gene Ther; 2010 Jan; 21(1):9-26. PubMed ID: 20017714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenging Standard-of-Care Paradigms in the Precision Oncology Era.
    Subbiah V; Kurzrock R
    Trends Cancer; 2018 Feb; 4(2):101-109. PubMed ID: 29458960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Personalized Oncology Meets Immunology: The Path toward Precision Immunotherapy.
    Mandal R; Chan TA
    Cancer Discov; 2016 Jul; 6(7):703-13. PubMed ID: 27107038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The changing face of clinical trials in the personalized medicine and immuno-oncology era: report from the international congress on clinical trials in Oncology & Hemato-Oncology (ICTO 2017).
    Golan T; Milella M; Ackerstein A; Berger R
    J Exp Clin Cancer Res; 2017 Dec; 36(1):192. PubMed ID: 29282151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The expanding role of the clinical haematologist in the new world of advanced therapy medicinal products.
    Lowdell MW; Thomas A
    Br J Haematol; 2017 Jan; 176(1):9-15. PubMed ID: 27748517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The innovative evolution of cancer gene and cellular therapies.
    Lam P; Khan G; Stripecke R; Hui KM; Kasahara N; Peng KW; Guinn BA
    Cancer Gene Ther; 2013 Mar; 20(3):141-9. PubMed ID: 23370333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current Status of Gene Engineering Cell Therapeutics.
    Saudemont A; Jespers L; Clay T
    Front Immunol; 2018; 9():153. PubMed ID: 29459866
    [No Abstract]   [Full Text] [Related]  

  • 13. Prospects for personalized combination immunotherapy for solid tumors based on adoptive cell therapies and immune checkpoint blockade therapies.
    Kato D; Yaguchi T; Iwata T; Morii K; Nakagawa T; Nishimura R; Kawakami Y
    Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(1):68-77. PubMed ID: 28539557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic biobanking, novel imaging techniques, and advanced molecular analysis for precise tumor diagnosis and therapy: The Polish MOBIT project.
    Niklinski J; Kretowski A; Moniuszko M; Reszec J; Michalska-Falkowska A; Niemira M; Ciborowski M; Charkiewicz R; Jurgilewicz D; Kozlowski M; Ramlau R; Piwkowski C; Kwasniewski M; Kaczmarek M; Ciereszko A; Wasniewski T; Mroz R; Naumnik W; Sierko E; Paczkowska M; Kisluk J; Sulewska A; Cybulski A; Mariak Z; Kedra B; Szamatowicz J; Kurzawa P; Minarowski L; Charkiewicz AE; Mroczko B; Malyszko J; Manegold C; Pilz L; Allgayer H; Abba ML; Juhl H; Koch F;
    Adv Med Sci; 2017 Sep; 62(2):405-413. PubMed ID: 28646744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychosocial Impact of Personalized Therapies in Oncology.
    Schilling G; Schulz-Kindermann F
    Recent Results Cancer Res; 2018; 210():181-190. PubMed ID: 28924686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene and cell therapy for pancreatic cancer.
    Singh HM; Ungerechts G; Tsimberidou AM
    Expert Opin Biol Ther; 2015 Apr; 15(4):505-16. PubMed ID: 25582170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.
    Drugs R D; 2007; 8(3):176-87. PubMed ID: 17472413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The future of new therapies in clinical medicine].
    Gálvez P; Ruiz A; Clares B
    Med Clin (Barc); 2011 Nov; 137(14):645-9. PubMed ID: 21397281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3rd international symposium on genetic anticancer agents.
    Wysocki PJ; Mackiewicz-Wysocka M
    Expert Opin Biol Ther; 2002 Jun; 2(5):565-8. PubMed ID: 12079492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (R)Evolutionary therapy: the potential of immunotherapy to fulfill the promise of personalized cancer treatment.
    Madan RA; Gulley JL
    J Natl Cancer Inst; 2015 Jan; 107(1):347. PubMed ID: 25432410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.